• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

Understanding neural networks using regression trees: an application to multiple myeloma survival data.

作者信息

Faraggi D, LeBlanc M, Crowley J

机构信息

Department of Statistics, University of Haifa, Haifa, 31905, Israel.

出版信息

Stat Med. 2001 Oct 15;20(19):2965-76. doi: 10.1002/sim.912.

DOI:10.1002/sim.912
PMID:11568952
Abstract

Neural networks are becoming very popular tools for analysing data. It is however quite difficult to understand the neural network output in terms of the original covariates or input variables. In this paper we provide, using readily available software, an easy way of understanding the output of the neural network using regression trees. We focus on the problem in the context of censored survival data for patients with multiple myeloma, where identifying groups of patients with different prognosis is an important aspect of clinical studies. The use of regression trees to help understand neural networks can be easily applied to uncensored situations.

摘要

相似文献

1
Understanding neural networks using regression trees: an application to multiple myeloma survival data.
Stat Med. 2001 Oct 15;20(19):2965-76. doi: 10.1002/sim.912.
2
Understanding neural networks using regression trees: an application to multiple myeloma survival data by D. Faraggi, M. LeBlanc and J. Crowley, Statistics in Medicine 2001; 20:2965-2976.
Stat Med. 2003 Feb 28;22(4):661; author reply 661-2. doi: 10.1002/sim.1355.
3
Survival analysis of censored data: neural network analysis detection of complex interactions between variables.删失数据的生存分析:神经网络分析检测变量间的复杂相互作用
Breast Cancer Res Treat. 1994;32(1):113-8. doi: 10.1007/BF00666212.
4
Psychosocial QOL is an independent predictor of overall survival in newly diagnosed patients with multiple myeloma.社会心理生活质量是新诊断的多发性骨髓瘤患者总生存期的独立预测因素。
Eur J Haematol. 2008 Nov;81(5):374-9. doi: 10.1111/j.1600-0609.2008.01126.x. Epub 2008 Jul 11.
5
International staging system for multiple myeloma.多发性骨髓瘤国际分期系统
J Clin Oncol. 2005 May 20;23(15):3412-20. doi: 10.1200/JCO.2005.04.242. Epub 2005 Apr 4.
6
Beta 2 microglobulin in multiple myeloma.多发性骨髓瘤中的β2微球蛋白
Am J Hematol. 1985 Dec;20(4):345-51. doi: 10.1002/ajh.2830200405.
7
Feed forward neural networks for the analysis of censored survival data: a partial logistic regression approach.用于截尾生存数据分析的前馈神经网络:一种偏逻辑回归方法。
Stat Med. 1998 May 30;17(10):1169-86. doi: 10.1002/(sici)1097-0258(19980530)17:10<1169::aid-sim796>3.0.co;2-d.
8
Comparison of serum beta 2-microglobulin and 24 hour urinary creatinine clearance as a prognostic factor in multiple myeloma.血清β2-微球蛋白与24小时尿肌酐清除率作为多发性骨髓瘤预后因素的比较。
J Korean Med Sci. 2006 Aug;21(4):639-44. doi: 10.3346/jkms.2006.21.4.639.
9
Erythropoiesis-stimulating agents are associated with reduced survival in patients with multiple myeloma.促红细胞生成素与多发性骨髓瘤患者生存率降低有关。
Am J Hematol. 2008 Sep;83(9):697-701. doi: 10.1002/ajh.21239.
10
Factors associated with recovery of renal function in patients with multiple myeloma who were treated with hemodialysis.与接受血液透析治疗的多发性骨髓瘤患者肾功能恢复相关的因素。
Nephron Clin Pract. 2011;117(1):c28-32. doi: 10.1159/000319644. Epub 2010 Aug 3.

引用本文的文献

1
Application of machine learning algorithms to predict postoperative surgical site infections and surgical site occurrences following inguinal hernia surgery.机器学习算法在预测腹股沟疝手术后手术部位感染和手术部位发生中的应用。
Hernia. 2024 Dec;28(6):2343-2354. doi: 10.1007/s10029-024-03167-w. Epub 2024 Sep 17.
2
Montreal prognostic score: estimating survival of patients with non-small cell lung cancer using clinical biomarkers.蒙特利尔预后评分:使用临床生物标志物评估非小细胞肺癌患者的生存情况。
Br J Cancer. 2013 Oct 15;109(8):2066-71. doi: 10.1038/bjc.2013.515. Epub 2013 Sep 24.